Company
Stimoxygen
Supercharging cancer treatment for the most resilient tumors
- Status
- Operatingas of 2026-09-19
- Business model
- B2B
- Headquarters
- Coleraine, Northern Ireland, United Kingdom
- Founded
- 2021
Claim, correct or request removal
Record updated 28 September 2026
About
For over 15 years, scientists at Ulster University have been developing stimulus responsive therapeutic systems, primarily to address the adverse effects associated with the use of cancer chemotherapeutic drugs. During those studies, the benefits of providing a transient, in situ source of molecular oxygen during therapy became abundantly clear and it was out of this that StimOxyGen was born.
Products
- Other
- StimOxyGen
Loading relationship preview